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INTRODUCTION
HLA-B27 associated uveitis is characterized by re-
current alternating acute unilateral attacks of in-
traocular inflammation in the anterior chamber (1,
2), and the intervals of them are a half year to sev-
eral years. On the other hand, the reported frequen-
cies of posterior segment involvement in HLA-B27
associated uveitis rage between 0 to 25.1% (1, 3-5).
The involvement was recognized as vitritis, cystoid
macular edema, or papillitis. Treatment of HLA-B27
associated uveitis is mainly topical corticosteroids
and mydriatic agents, while systemic corticosteroid
administration is required in 24% of the patients to
control the inflammations (5).
Here we report a case of HLA-B27 associated
uveitis that showed repeated exacerbations and de-
veloped retinal and vitreous hemorrhages.
CASE REPORT
A 34-year-old man suffered from blurred vision
and ocular pain in his right eye, and was treated
with topical and systemic corticosteroids. However,
his symptoms did not improve, and then, he was re-
ferred 2 weeks later to our hospital on December 16,
2002. His visual acuities were 14/20 OD and 20/20
OS. Intraocular pressures were 16 mmHg OD, and
14 mmHg OS. Biomicroscopy showed remarkable
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ciliary injection and severe inflammation in the an-
terior chamber with 3+ flare and 3+ cells, fibrin
production and hypopyon in the right eye. Almost
360 degrees of posterior synechiae and pigmenta-
tion on the lens were noted. Fundus examination
showed no particular findings at that time. The left
eye was normal. Peripheral blood test detected posi-
tive for HLA-B27. From these clinical and serologi-
cal findings, we diagnosed the case as HLA-B27 as-
sociated uveitis OD. Other systemic diseases asso-
ciated with HLA-B27 such as ankylosing spondyli-
tis, inflammatory bowel diseases or Reiter’s syn-
drome (6) were not remarkable. In addition to eye
drops of mydriasis and betamethazone, oral pred-
nisolone of 40 mg/day for 3 days and 30 mg/day for
3 days was administrated. Since intraocular inflamma-
tion improved and posterior synechiae were disolved,
oral corticosteroid administration could be stopped.
However, 1 week later, right fundus showed dif-
fuse vitreous opacity and mild dilatation of retinal
vessels (Fig. 1a). He was given oral prednisolone
again from 40 mg/day. Fundus findings gradually im-
proved and oral prednisolone was decreased. Hence
right visual acuity was recovered to 14/20 on Janu-
ary 16, 2003. Gradually, remained vitreous opacity
resolved, and the inflammation in his right eye dis-
appeared for 2 months. However, he complained of
blurred vision in his right eye again. Although in-
flammation in the anterior segment was minimal, fun-
dus examination showed obvious irregular dilatation
of retinal vein and several small retinal hemorrhages
as well as hyperemic optic disc in the posterior pole
in the right eye on March 11, 2003 (Fig. 1b). At that
time although we performed fundus flurorescein
angiography, leakage from vessels or neovasculari-
zation was not observed (Fig. 1c). After a week, his
visual acuity suddenly decreased to 2/200 in OD,
and fundus examination showed vitreous hemor-
rhage (Fig. 1d). In addition to topical corticoster-
oids, oral prednisolone was administrated again from
40 mg/day and was gradually decreased. As vitre-
ous and retinal hemorrhages improved, visual acu-
ity recovered to 20/20 OD on April 8, 2003. Through
the decreased vitreous hemorrhage, Weiss ring upon
the optic disc was detected. The summary of clini-
cal course is shown in Fig. 2. He has had no recur-




Fig. 1. Fundus examination (a, b, d) and fluorescein angiography (c) in the right eye. A week after the first discharge, diffuse vit-
reous opacity and mild dilatation of retinal vessels are observed on January 7, 2003 (a). Fundus examination shows obvious irregular
dilatation of retinal veins, and small retinal hemorrhage as well as hyperemic optic disc in the posterior pole of right eye on March
11, 2003 : 1 week before the appearance of vitreous hemorrhage (b). At this time fundus flurorescein angiography demonstrated no
leakage from vessels or neovascularization (c). Right fundus shows vitreous hemorrhage on March 17, 2003 (d).
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DISCUSSION
HLA-B27 associated uveitis is characterized by
younger age at onset, high male to female ratio, fre-
quent unilateral altering eye involvement, severe ocu-
lar symptom during activity such as presence of fi-
brin in the anterior chamber (1). D’Alessandro, et
al. demonstrated that HLA-B27 associated uveitis
was the most common cause of hypopyon uveitis
(7). Taken together, intraocular inflammation of this
case showed at first visit to our hospital was consis-
tent with previous reports in HLA-B27 associated
uveitis.
HLA-B27 associated uveitis is one of the common
forms in intraocular inflammation showing acute
anterior uveitis (AAU) (8, 9). Recently, it is reported
that the frequencies of posterior segment involve-
ment in the uveitis rage between 0 to 25.1% (3, 5,
10, 11). It is reported that the involvement of pos-
terior segment is recognized as vitritis, cystoid macu-
lar edema, papillitis and retinal vasculitis (5, 12) and
it is suggested to occur secondary to anterior seg-
ment intraocular inflammation (3). In this case after
improvement of AAU, diffuse vitreous opacity and
retinal vessel dilatation, and moreover retinal and vit-
reous hemorrhage were noted.
Vitreous hemorrhage is extravasated blood within
the space bordered by the internal limiting mem-
brane of the retina (13). Posterior vitreous detach-
ment (PVD) is one of the common causes of vitre-
ous hemorrhage (13). Weiss ring is a circular reti-
nal grial adhesion to the optic disc, which has close
association with PVD (14). In our case, before the
onset of vitreous hemorrhage, right fundus showed
prominent retinal vein dilatation and retinal hem-
orrhage, suggesting that severe exacerbation of
inflammation occurred in the posterior segment. In
addition, Weiss ring was detected through the vitre-
ous hemorrhage, indicating PVD had constituted in
exacerbation of inflammation. These clinical courses
might have been correlated with onset of vitreous
hemorrhage.
Usually recurrence happens after the intervals
about a half to several years, and it must start with
acute inflammation of the anterior segment. The
inflammations observed during the treatments in
our case involved minimal inflammations of ante-
rior segment and severe inflammation of posterior
Fig. 2. Clinical course in alteration of visual acuity, anterior segment intraocular inflammation, fundus examination of his right eye,
and administration of oral prodnisolone is summarized.
VA, visual acuity ; PSL, prednisolone ; ASII, anterior segment intraocular inflammation.
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segment such as retinal vein dilatation, retinal hem-
orrhage, and hyperemic optic disc. This suggests
that the repeated inflammations during the treat-
ments in this case were exacerbation, but not re-
currence. Treatment of HLA-B27 associated uveitis
generally involves topical application of corticoster-
oid preparations to control the inflammation, and the
treatment is generally effective. However, some pa-
tients with HLA-B27 associated uveitis are difficult
to treat, and require systemic corticosteroid admini-
stration. In this case, systemic corticosteroid admini-
strations were needed and repeated exacerbations oc-
curred. Although this is not typical case of HLA-B27
associated uveitis, we should pay attention to the fact
that severe exacerbation can occur even after re-
solving inflammation in HLA-B27 associated uveitis.
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